Joe Seaman, Head of Client Relations at Naturalis London, tells us how the firm is providing quality CBD, trusted education and tailored consumer advice
Today, CBD is creating a buzz around the globe, with the UK being no exception. According to the CMC (Centre for Medical Cannabis), it is already a £300 million market, eclipsing the Vitamin C and D industries combined. With forecasts predicting it will peak £1 billion by 2025 in the UK alone, the volume of CBD companies and products is likely to continue rising for the foreseeable future. (1)
Education of CBD
With CBD’s continued rise in popularity, there is also a need for further education and public understanding to ensure consumers are aware of what it is they are purchasing, how best to take the product and which product best suits their needs. A better understanding of CBD can begin with an understanding of our endocannabinoid system (ECS).
The ECS is a modulatory (regulatory) system existent in living organisms, which controls several different functions such as:
- Appetite
- Digestion
- Immune function
- Inflammation, including neuroinflammation.
- Mood
- Sleep
- Reproduction/fertility
- Motor control
- Temperature regulation
- Memory
- Pain
- Pleasure/reward (2)
The ECS itself is made up of three parts:
- Endocannabinoids, such as anandamide and GABA.
- Receptors found in the nervous system and around your body that endocannabinoids and cannabinoids bond with.
- Enzymes that help break down endocannabinoids and cannabinoids.
Cannabinoid receptors are comprised of CB1 and CB2 receptors. CB1 receptors are found mainly in the central nervous system and the brain, whereas CB2 receptors are present largely within the immune system (white blood cells, spleen, gut, etc.) This explains why cannabinoids, such as CBD can have an effect both mentally and physically. Due to its interaction with the ECS, CBD can be taken in a multitude of forms from oils, topicals, edibles, to vapes and drinks.
Therefore, we at Naturalis have carefully tailored a range of products that suit a particular need and requirement. Today, Naturalis London is one of the leading companies within the CBD space in providing both quality CBD and consumer education. However, we are always researching into new methods and practices on how to incorporate CBD into your daily lifestyle and therefore always have new, innovative products in the research and development stage of production.
Regulation of CBD
We believe CBD is not just about the end-product; it represents a change in society in favour of more natural forms of self-care and improvement. However, the commercialisation of CBD has at times come in conflict with the potential medical value that cannabidiol provides, leading to calls for tighter regulations and inspection within this flourishing industry. Currently, there is little regulatory framework for CBD companies to adhere to which can lead to potential issues relating to accurate labelling, correct CBD content in products and unsubstantiated medical claims made through marketing material.
Therefore, Naturalis welcomes any proportionate regulations put in place within the UK to ensure this industry’s continued success, safety and longevity. We have worked hard to create compliancy and transparency in our product range from our manufacturing processes, our third-party lab testing and specific labelling requirements needed for CBD products. The CBD industry has significant potential for future developments into business and medical sectors. At Naturalis London, we aim to be the pioneers of both these industries through ensuring high-quality CBD, trusted education and tailored consumer advise. We are happy to share our knowledge and experience with those who are interested in knowing more about CBD and the positive impact it can have on our society.
References
- CBD IN THE UK: https://irp-cdn.multiscreensite.com/51b75a3b/files/uploaded/Exec%20Summary%20-%20CBD%20.pdf
- The role of the endocannabinoid system in the regulation of endocrine function and in the control of energy balance in humans: http://www.phmd.pl/api/files/view/2117.pdf
Please note: This is a commercial profile
